SPY344.61+1.88 0.55%
DIA283.65+1.68 0.60%
IXIC11,506.01+21.31 0.19%

UBS Maintains Sell on Mednax, Raises Price Target to $14

UBS maintains Mednax (NYSE:MD) with a Sell and raises the price target from $11 to $14.

· 10/06/2020 07:47
UBS maintains Mednax (NYSE:MD) with a Sell and raises the price target from $11 to $14.